Mitsuhiro Kato Selected Research

Lissencephaly

1/2016	In vitro characterization of neurite extension using induced pluripotent stem cells derived from lissencephaly patients with TUBA1A missense mutations.
2/2014	A case of TUBA1A mutation presenting with lissencephaly and Hirschsprung disease.
1/2013	Post-natal treatment by a blood-brain-barrier permeable calpain inhibitor, SNJ1945 rescued defective function in lissencephaly.
2/2004	Mutations of ARX are associated with striking pleiotropy and consistent genotype-phenotype correlation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mitsuhiro Kato Research Topics

Disease

17	Seizures (Absence Seizure) 02/2022 - 08/2007
14	Brain Diseases (Brain Disorder) 01/2022 - 12/2006
9	Intellectual Disability (Idiocy) 12/2018 - 04/2005
9	Infantile Spasms (West Syndrome) 11/2018 - 08/2006
7	Epilepsy (Aura) 02/2021 - 06/2010
5	Neurodevelopmental Disorders 02/2022 - 01/2018
5	Drug Resistant Epilepsy 01/2021 - 04/2015
4	Narcolepsy 04/2022 - 01/2015
4	Lissencephaly 01/2016 - 02/2004
3	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2021 - 10/2019
3	Cataplexy 12/2018 - 01/2015
3	Infantile Epileptic-Dyskinetic Encephalopathy 04/2016 - 08/2007
3	Spasm (Spasms) 06/2015 - 07/2010
2	Idiopathic Hypersomnia 04/2022 - 01/2015
2	Focal Cortical Dysplasia 01/2022 - 01/2013
2	Focal cortical dysplasia of Taylor 01/2022 - 07/2021
2	Malformations of Cortical Development 12/2021 - 01/2021
2	Chorea (Rheumatic Chorea) 01/2021 - 04/2018
2	Dyskinesias (Dyskinesia) 01/2021 - 01/2020
2	Aromatic amino acid decarboxylase deficiency 01/2020 - 06/2010
2	Ataxia (Dyssynergia) 10/2019 - 05/2007
2	Disorders of Excessive Somnolence (Hypersomnia) 12/2018 - 02/2015
2	Atrophy 09/2017 - 01/2013
2	Megalencephaly 04/2017 - 08/2007
2	Schizencephaly 03/2017 - 01/2013
2	Classical Lissencephalies and Subcortical Band Heterotopias 01/2016 - 04/2005
2	Muscular Diseases (Myopathy) 01/2013 - 10/2012
2	Porencephaly 01/2013 - 01/2012
2	Alexander Disease (Alexander's Disease) 10/2004 - 03/2002
1	Body Weight (Weight, Body) 01/2022
1	Partial Epilepsies (Epilepsy, Partial) 01/2022
1	CDKL5 deficiency disorder 04/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021
1	Glycosylphosphatidylinositol deficiency 01/2021
1	Autistic Disorder (Autism) 01/2021
1	Vomiting 01/2020
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020
1	Craniofacial Abnormalities 01/2020
1	Scoliosis 10/2019
1	3 Early Infantile Epileptic Encephalopathy 10/2019
1	Movement Disorders (Movement Disorder) 01/2019
1	Syncope (Fainting) 04/2018

Drug/Important Bio-Agent (IBA)

7	Anticonvulsants (Antiepileptic Drugs)IBA 07/2021 - 07/2010
5	Adrenocorticotropic Hormone (ACTH)FDA Link 08/2018 - 09/2013
4	TubulinIBA 12/2021 - 02/2014
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2016
4	polyalanineIBA 08/2007 - 02/2004
3	Carbamazepine (Tegretol)FDA LinkGeneric 02/2022 - 07/2013
3	HLA-DQB1 antigen (HLA DQB1)IBA 12/2018 - 01/2015
3	SpectrinIBA 09/2017 - 06/2010
2	Adenosine Triphosphatases (ATPase)IBA 01/2022 - 01/2018
2	Sirolimus (Rapamycin)FDA Link 01/2022 - 07/2021
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2013
2	perampanelIBA 01/2021 - 10/2019
2	CytokinesIBA 01/2021 - 03/2002
2	Collagen Type IV (Type IV Collagen)IBA 01/2021 - 01/2012
2	Serotonin (5 Hydroxytryptamine)IBA 01/2020 - 01/2019
2	Vitamin B 6IBA 12/2018 - 09/2013
2	HLA Antigens (Human Leukocyte Antigens)IBA 12/2018 - 02/2015
2	UDP-galactose translocatorIBA 03/2017 - 12/2013
2	Heterotrimeric GTP-Binding Proteins (Heterotrimeric G-Proteins)IBA 01/2017 - 09/2013
2	DNA (Deoxyribonucleic Acid)IBA 10/2016 - 01/2016
2	Nonsense Codon (Nonsense Mutation)IBA 04/2016 - 02/2004
2	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 08/2014 - 05/2014
2	Topiramate (Topamax)FDA LinkGeneric 09/2013 - 07/2013
2	AutoantibodiesIBA 05/2007 - 05/2007
2	Glutamate Receptors (Glutamate Receptor)IBA 05/2007 - 05/2007
2	Glial Fibrillary Acidic ProteinIBA 10/2004 - 03/2002
1	OrexinsIBA 04/2022
1	Glutamic Acid (Glutamate)FDA Link 02/2022
1	NucleotidesIBA 01/2022
1	Red DND-99IBA 01/2022
1	Ethosuximide (Zarontin)FDA LinkGeneric 01/2022
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022
1	CyclinsIBA 04/2021
1	ElementsIBA 01/2021
1	KinesinsIBA 01/2021
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2021
1	Kainic Acid (Kainate)IBA 01/2021
1	Immunoglobulin D (IgD)IBA 01/2021
1	Nuclear Localization Signals (Nuclear Localization Signal)IBA 01/2021
1	Dopamine (Intropin)FDA LinkGeneric 01/2020
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2020
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2020
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2020
1	RNA Splice SitesIBA 10/2019
1	CatecholaminesIBA 01/2019
1	Aromatic-L-Amino-Acid DecarboxylasesIBA 01/2019
1	VitaminsIBA 12/2018
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2018
1	Pyridoxal Phosphate (Pyridoxal 5 Phosphate)IBA 12/2018
1	Pyridoxine (Pyridoxin)FDA LinkGeneric 12/2018
1	Protein Phosphatase 1IBA 11/2018
1	UbiquitinIBA 08/2018
1	EnzymesIBA 08/2018

Therapy/Procedure

7	Therapeutics 01/2022 - 05/2007
2	Artificial Respiration (Mechanical Ventilation) 10/2019 - 10/2012
1	Ketogenic Diet 01/2022
1	Electrocoagulation (Electrocautery) 01/2021
1	Tracheotomy 10/2019